Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Lilly Discontinues Phase 3 Rheumatoid Arthritis Program For Tabalumab Based On Efficacy Results

 

Lilly Discontinues Phase 3 Rheumatoid Arthritis Program For Tabalumab Based On Efficacy Results

2013-02-08 09:17:08| Biotech - Topix.net

Eli Lilly and Company announced today that it will discontinue the Phase 3 rheumatoid arthritis program for tabalumab, an anti-BAFF monoclonal antibody, due to lack of efficacy.

Tags: results based program phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

05.10 Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories 05.10 Hurricane Kirk Graphics 05.10 Hurricane Kirk Forecast Discussion Number 24 05.10 Hurricane Kirk Wind Speed Probabilities Number 24 05.10 Hurricane Kirk Forecast Advisory Number 24 05.10 Hurricane Kirk Public Advisory Number 24 05.10 Summary for Hurricane Kirk (AT2/AL122024) 05.10 Hurricane Leslie Graphics More »